XBI, which is a biotech ETF, is showing a potential bearish 2-1-2 continuation on the quarterly chart. Because of this, I will be looking at biotech stocks for a short.
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
XBI, which is a biotech ETF, is showing a potential bearish 2-1-2 continuation on the quarterly chart. Because of this, I will be looking at biotech stocks for a short.